Skip to content

Supplier News

Archimedes gets OK for fentanyl nasal spray

Archimedes Pharma Ltd. and its subsidiary Archimedes Pharma U.S. Inc. have been cleared by the U.S. Food and Drug Administration to market approved Lazanda (fentanyl) nasal spray, for the management of breakthrough pain in cancer patients.

FTC settles over Nivea skin cream claims

The Federal Trade Commission has reached a settlement requiring Nivea skin cream maker Beiersdorf Inc. to stop claiming that regular use of its Nivea My Silhouette! cream can significantly reduce consumers’ body size.

Abbott reports stolen diabetes products

Abbott Diabetes Care is working with the Food and Drug Administration’s Office of Criminal Investigations, the Federal Bureau of Investigation and other law enforcement officials to recover a stolen shipment of blood glucose monitoring products.

Lannett gets OK for morphine sulfate solution

Lannett Co. has received Food and Drug Administration approval for its 505(b)(2) New Drug Application (NDA) for morphine sulfate oral solution. Lannett said Friday that it expects to begin shipping the pain relief drug soon.

Newell Rubbermaid names Polk as CEO

Former Unilever executive Michael Polk has been appointed president and chief executive officer at Newell Rubbermaid. The general merchandise maker said late Thursday that Polk, 50, is slated to take the helm as CEO on July 18.

Mylan set to ship Entocort generic

In the wake of a court decision, Mylan Inc. plans to roll out enteric-coated budesonide capsules, a medication for Crohn’s disease. The company said late Thursday that the U.S. District Court for the District of Delaware ruled that its Mylan Pharmaceuticals Inc.

Dr. Reddy’s launches generic Levaquin

Dr. Reddy’s Laboratories this week began shipping levofloxacin tablets in the U.S. market after receiving Food and Drug Administration approval for the antibiotic medication. The company said Wednesday that it’s offering levofloxacin tablets, a bioequivalent generic version of Daiichi Sankyo Co.